News Results

There are 621,150 News Results

Jun 19, 2025
Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline | DelveInsight
The delta-like ligand 3 targeted therapies market is witnessing significant growth, driven by the rising incidence of small cell lung cancer (SCLC) and neuroendocrine tumors. Advancements in antibody-drug conjugate (ADC)...
Jun 19, 2025
HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During the Study Period (2020-2034) | DelveInsight
The future of the HER2-low cancer treatment market is poised for significant transformation, driven by the approval of ENHERTU and the advancement of other innovative antibody-drug conjugates (ADCs) like DATROWAY,...
Jun 20, 2025
TELUS Announces Cash Tender Offers for Eight Series of Debt Securities
VANCOUVER, BC, June 20, 2025 /PRNewswire/ - TELUS Corporation ("TELUS" or the "Company") today announced the commencement of separate offers (the "Offers") to purchase for cash up to C$600,000,000 (the...
Jun 20, 2025
TELUS ANNOUNCES CASH TENDER OFFERS FOR TWO SERIES OF DEBT SECURITIES
VANCOUVER, B.C., June 20, 2025 /PRNewswire/ - TELUS Corporation (the "Company") announced today the commencement of separate offers (the "Offers") to purchase for cash any and all of the two...
Jun 23, 2025
RESULTS FROM AMGEN'S PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS
MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau, and Delivered Significant Cardiometabolic Improvements at 52 Weeks
Jun 23, 2025
Sarcopenia Market to Register Sustainable Growth at a CAGR of 8.1% During the Study Period (2020-2034) | DelveInsight
The sarcopenia market size shall grow during the forecast period (2025-2034) due to the launch of upcoming therapies and the increasing cases of sarcopenia. This market is expected to increase...
Jun 24, 2025
REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic Dermatitis
Achieved statistical significance on primary endpoint at week 16 for mean percent change in EASI score from baseline for all rezpegaldesleukin arms versus placebo
Jun 26, 2025
iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results
BEIJING, June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results...
Jun 27, 2025
Lithium-ion Battery Market | A $182.5B Industry by 2030 | How EV Adoption and the Energy Transition Are Powering Global Demand | The Research Insights
CHICAGO and PUNE, India, June 27, 2025 /PRNewswire/ --
Jun 30, 2025
U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
-- SKINVIVE by JUVÉDERM® is currently approved in the U.S. as the first and only hyaluronic acid microdroplet injectable indicated to improve cheek skin smoothness. -- If approved, SKINVIVE by...
62115

Pages

1

Stories of the day

Aug 28, 2025
BAE Systems delivers 1,000th THAAD seeker for ballistic missile defense program
Aug 29, 2025
GA-ASI Marks Another Aviation First With YFQ-42A CCA Flight Testing
Aug 29, 2025
Omnisys Highlights BRO™: A Unique System for Smart Combat Mission Planning and...
Aug 29, 2025
Saab reveals new Counter-UAS missile Nimbrix